Compounds > imatinib
Page last updated: 2024-08-16

imatinib and pd 173955

imatinib has been researched along with pd 173955 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bornmann, WG; Clarkson, B; Kuriyan, J; Miller, WT; Nagar, B; Pellicena, P; Schindler, T; Veach, DR1
Caligiuri, M; Kaplan, F; Kley, N; Lievens, S; Liu, Q; Majeti, JZ; Molz, L; Murthi, K; Ramos-Kelsey, R; Tavernier, J; Xu, JP1
Adrián, FJ; Gray, NS; Lee, C; Liu, Y; Nagle, A; Okram, B; Ren, P; Sim, T; Spraggon, G; Wang, X; Warmuth, M; Xia, G; Xie, Y1
Ahmed, S; Belloni, V; Gambacorti-Passerini, C; Gasser, M; Gunby, RH; Mologni, L; Redaelli, S; Scapozza, L; Sottocornola, R; Tartari, CJ1
Ciceri, P; Davis, MI; Herrgard, S; Hocker, M; Hunt, JP; Pallares, G; Treiber, DK; Wodicka, LM; Zarrinkar, PP1

Other Studies

5 other study(ies) available for imatinib and pd 173955

ArticleYear
Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571).
    Cancer research, 2002, Aug-01, Volume: 62, Issue:15

    Topics: Amino Acid Sequence; Animals; Benzamides; Crystallography, X-Ray; Enzyme Activation; Enzyme Inhibitors; Imatinib Mesylate; Mice; Molecular Sequence Data; Piperazines; Protein Conformation; Protein Structure, Tertiary; Proto-Oncogene Proteins c-abl; Pyridones; Pyrimidines; Structure-Activity Relationship

2002
MASPIT: three-hybrid trap for quantitative proteome fingerprinting of small molecule-protein interactions in mammalian cells.
    Chemistry & biology, 2006, Volume: 13, Issue:7

    Topics: Blotting, Western; Cell Line; DNA, Complementary; Flow Cytometry; Humans; Kinetics; Proteins; Proteome; Pyridones; Pyrimidines

2006
A general strategy for creating "inactive-conformation" abl inhibitors.
    Chemistry & biology, 2006, Volume: 13, Issue:7

    Topics: Adenosine Triphosphate; Crystallography; Enzyme Inhibitors; Hydrogen Bonding; Models, Molecular; Molecular Conformation; Phosphorylation; Proto-Oncogene Proteins c-abl; Structure-Activity Relationship; Substrate Specificity

2006
Structural insights into the ATP binding pocket of the anaplastic lymphoma kinase by site-directed mutagenesis, inhibitor binding analysis, and homology modeling.
    Journal of medicinal chemistry, 2006, Sep-21, Volume: 49, Issue:19

    Topics: Adenosine Triphosphate; Amino Acid Sequence; Anaplastic Lymphoma Kinase; Aniline Compounds; Benzamides; Binding Sites; Catalytic Domain; Cells, Cultured; Computer Simulation; Humans; Imatinib Mesylate; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Nitriles; Piperazines; Point Mutation; Protein Conformation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridones; Pyrimidines; Quinolines; Receptor Protein-Tyrosine Kinases; Sequence Homology, Amino Acid

2006
Comprehensive analysis of kinase inhibitor selectivity.
    Nature biotechnology, 2011, Oct-30, Volume: 29, Issue:11

    Topics: Catalysis; Drug Design; Enzyme Stability; High-Throughput Screening Assays; Humans; Protein Binding; Protein Kinase Inhibitors; Protein Kinases; Proteomics; Signal Transduction; Substrate Specificity

2011